Friday, August 01, 2014 11:07:32 AM
Prediction: Warrants are due to expire Aug 15 (though they have already extended several times, the last time was after they said it was a final extension…and when they extended again, so who knows). they will do a release early next week to juice the SP so once again the insiders can make money. Of course the sell off by these warrant holders will ultimate drive the SP down where it will stay.
The release will either be Tox is scheduled to start, the lab has been sold to Diwan (though not sure how they think that will be perceived as good news, even at cost, all he did was wash his NNVC shares and now they're cash) or something about Ebola that will be truly fluff.
Announcing the start of Tox will give them at least another 2-4 years of milking the company, including bonuses, salary, and payments to their own companies, trips to Europe, family payroll checks and gift shares.
Why do I say this?
- The announcement buys them at least 6-12 months
- They wait another 3-6 for the outcry to force them to say something about the status of Tox, which will be the announcement of Tox completion
- Then they announce that they must now compile and analyze the data and write up the formal report. That's good for another 6-12 months.
And most will feel that they are on time and meeting all their deadlines.
The only variable is how strong the out cry will be, which if history is any indicator, will be minimal
They don't do anything because they don't have to. They make millions/year, and are heralded as doing what best for the company and the shareholders.
I applaud them for the flawless execution, but milking a shell with the promise of "game changing" product isn't a new game. It is as old as snake oil.
Wait for it.
The SwingTrade Portfolio is up 28.3% YTD through 5/30/2014, 83.5% in 2013, and 475.5% since inception.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=102716798
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM